Episode 2 (December 22, 2023): Interview with President and CEO of Tome Biosciences, Rahul Kakkar; intelligent lab partner using LLMs; AI for antimicrobials; mRNA vaccine production in Africa; Moderna’s positive cancer vaccine data.

Listed below are key references to the GEN stories, media and other items discussed in this episode of Touching Base:

• The Next Chapter in Genome Editing? Tome Emerges from Stealth with $213M By Alex Philippidis, GEN, December 19, 2023.
• Artificial Intelligence-Based Lab Partner Designs, Runs Experiments in the Lab GEN, December 20, 2023.
• BioNTech Advances Plans for mRNA Vaccine Production in Africa by 2025 GEN, December 19, 2023.
• Explainable AI Directs Small Molecule Structural Class Drug Discovery By Jonathan Grinstein, GEN, December 20, 2023.
• StockWatch: Positive Cancer Vaccine Data Wows Moderna Investors By Alex Philippidis, GEN Edge, December 18, 2023.

Hosted on Acast. See acast.com/privacy for more information.

Episode 1 (Week ending December 8, 2023): Nevan Krogan (UCSF) mapping autism pathways; Nvidia’s latest AI partnership; CAR-T regulations; epigenome editing; mRNA therapeutics.

References to the GEN stories, media and other items discussed in this episode of Touching Base:

·        Autism’s Molecular Mechanisms Uncovered through Protein-Protein Interaction Network

By Julianna Lemieux, GEN, December 5, 2023.

·        Rhapsody in B: Tune Therapeutics Presents Data for Hepatitis B Epigenetic Silencer

By Jonathan Grinstein, GEN Edge, December 6, 2023.

·        Nvidia Looks to Genentech for its Next Leap in AI Drug Discovery

By Alex Philippidis, GEN Edge, November 28, 2023.

·        StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers

By Alex Philippidis, GEN, December 1, 2023

·        Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning {VIDEO}

GEN Edge, August 30, 2023

·        Press release: John Crowley appointed President & CEO of BIO

Biotechnology Innovation Organization

·        BIO CEO Rachel King Outlines Industry’s Challenges on “Close to the Edge”

GEN multimedia, April 26, 2023

·        The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease

GEN, November 16, 2023

Hosted on Acast. See acast.com/privacy for more information.